With the analysis among 422 patents, we discovered top 160 key players by total patent application. OSI Pharmaceuticals, Inc., Bristol Myers Squibb Co., Oncogene Science, Inc. are dominant in this area. They take 12.80% of the total patent filing.
OSI Pharmaceuticals, Inc.
New York, United States
Patent: 24
New York, United States
Patent: 15
New York, United States
Patent: 15
Regents of the University of California
California, United States
Patent: 14
Massachusetts, United States
Patent: 13
Golden Biotechnology Corp.
Taiwan Province, China
Patent: 12
Vaud, Switzerland
Patent: 11
Scripps Clinic & Research Foundation
California, United States
Patent: 11
California, United States
Patent: 10
With the analysis among 15 patents, we discovered top 7 start-ups by total patent application. GeneMedicine, DRAGONFLY Therapeutics, Inc., Asana BioSciences LLC are active in this area.
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 2
New Jersey, United States
Patent: 2
Bluefin Biomedicine, Inc.
Massachusetts, United States
Patent: 2
Shenzhen Evergreen Therapeutics Co., Ltd.
Guangdong Sheng, China
Patent: 1
Cygnal Therapeutics, Inc.
Massachusetts, United States
Patent: 1
With the analysis among related 140 patents applied in the last 5 years. We discover 102 most active companies in this area. The fast-growing Guizhou University, Shandong Boan Biotechnology Co., Ltd., Soochow University take 20.71% of patent filing during this period.
Guizhou Sheng, China
Patent: 15
Shandong Boan Biotechnology Co., Ltd.
Shandong Sheng, China
Patent: 8
Jiangsu Sheng, China
Patent: 6
Xi'an Jiaotong University
Shaanxi Sheng, China
Patent: 2
Tokyo Metropolitan Institute of Medical Science
Hubei Sheng, China
Patent: 2
Japanese Foundation for Cancer Research
Postech Academy - Industry Foundation
Nordrhein-Westfalen, Germany
Patent: 2
With the analysis among related 140 patents in last 5 years, we discover 81 new entrants. Shandong Boan Biotechnology Co., Ltd., Dalian Blue Peptide Technology Research & Development Co.Ltd, DRAGONFLY Therapeutics, Inc. are the most active new entrants in this area.
Shandong Boan Biotechnology Co., Ltd.
Shandong Sheng, China
Patent: 8
Dalian Blue Peptide Technology Research & Development Co.Ltd
Liaoning Sheng, China
Patent: 2
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 2
Nordrhein-Westfalen, Germany
Patent: 2
Xi'an Jiaotong University
Shaanxi Sheng, China
Patent: 2
Hubei Sheng, China
Patent: 2
Postech Academy - Industry Foundation
Nordrhein-Westfalen, Germany
Patent: 2
Nanjing University of Chinese Medicine
Jiangsu Sheng, China
Patent: 2
With the analysis among 227 patents, we discovered top 72 universities and scientific research institutions by total patent application. Guizhou University, Shanghai Institute of Materia Medica Chinese Academy of Sciences, Capital University of Medical Sciences are dominant in this area. They take 20.70% of the total patent filing.
Guizhou Sheng, China
Patent: 22
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 11
Capital University of Medical Sciences
Beijing Shi, China
Patent: 8
Jiangsu Sheng, China
Patent: 8
The Scripps Research Institute
California, United States
Patent: 6
Huazhong University of Science & Technology
Hubei Sheng, China
Patent: 5
Shanghai Institute of Organic Chemistry
Shanghai Shi, China
Patent: 5
North Carolina, United States
Patent: 3
University of Massachusetts
Massachusetts, United States
Patent: 3
Guizhou Sheng, China
Patent: 3